2023 Form 5500 filing — Allergy Asthma & Immunology As 401(K) Profit Sharing Plan & Trust
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240710095405NAL0008488579001) for Allergy Asthma & Immunology As 401(K) Profit Sharing Plan & Trust, reported by Allergy Asthma & Immunology As under EIN 86-0217027 and plan number 001. It reports 36 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).
Form 5500 2 · 2023
Filing snapshot
Net assets (EOY)$2.3MReported net assets$2,318,312
Participants36
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
- EFAST2 acknowledgement
- 20240710095405NAL0008488579001
- Plan sponsor
- Allergy Asthma & Immunology As
- EIN
- 86-0217027
- Plan number
- 001
- Location
- Scottsdale, AZ
- Received date
- not reported in the loaded dataset
How to read this filing
- This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
- Schedule chips (Sch H / I / C) show which schedules this filing includes.
- Net assets = total assets minus total liabilities (Schedule H/I).
- Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
- For the plan's full history, open the plan profile.
Schedule I · 2023
Reported financial snapshot
Reported figures as filed, in whole dollars. Only fields the filing reports are shown.
Reported balance (end of year)$2.3M total assets
Net assets$2.3MLiabilities$0
Full reported line items
- Total assets (EOY)
- $2,318,312
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $2,318,312
- Employer contributions
- $82,686
- Participant contributions
- $197,030
- Total income / additions
- $585,134
- Benefits paid
- $29,447
- Administrative expenses
- $14,492
- Total expenses
- $43,939
- Net increase / (decrease)
- $541,195
Frequently asked questions
- What does EFAST2 acknowledgement 20240710095405NAL0008488579001 cover?
- It is the 2023 Form 5500 filing for Allergy Asthma & Immunology As 401(K) Profit Sharing Plan & Trust, reported by Allergy Asthma & Immunology As (EIN 86-0217027).
- Which Form 5500 schedules are attached to this 2023 filing?
- Attached schedules in the loaded dataset include Schedule I (small plan financials).